Cargando…

Vascular Effects of Ultrafine Particles in Persons with Type 2 Diabetes

BACKGROUND: Diabetes confers an increased risk for cardiovascular effects of airborne particles. OBJECTIVE: We hypothesized that inhalation of elemental carbon ultrafine particles (UFP) would activate blood platelets and vascular endothelium in people with type 2 diabetes. METHODS: In a randomized,...

Descripción completa

Detalles Bibliográficos
Autores principales: Stewart, Judith C., Chalupa, David C., Devlin, Robert B., Frasier, Lauren M., Huang, Li-Shan, Little, Erika L., Lee, Steven M., Phipps, Richard P., Pietropaoli, Anthony P., Taubman, Mark B., Utell, Mark J., Frampton, Mark W.
Formato: Texto
Lenguaje:English
Publicado: National Institute of Environmental Health Sciences 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002188/
https://www.ncbi.nlm.nih.gov/pubmed/20822968
http://dx.doi.org/10.1289/ehp.1002237
_version_ 1782193705611952128
author Stewart, Judith C.
Chalupa, David C.
Devlin, Robert B.
Frasier, Lauren M.
Huang, Li-Shan
Little, Erika L.
Lee, Steven M.
Phipps, Richard P.
Pietropaoli, Anthony P.
Taubman, Mark B.
Utell, Mark J.
Frampton, Mark W.
author_facet Stewart, Judith C.
Chalupa, David C.
Devlin, Robert B.
Frasier, Lauren M.
Huang, Li-Shan
Little, Erika L.
Lee, Steven M.
Phipps, Richard P.
Pietropaoli, Anthony P.
Taubman, Mark B.
Utell, Mark J.
Frampton, Mark W.
author_sort Stewart, Judith C.
collection PubMed
description BACKGROUND: Diabetes confers an increased risk for cardiovascular effects of airborne particles. OBJECTIVE: We hypothesized that inhalation of elemental carbon ultrafine particles (UFP) would activate blood platelets and vascular endothelium in people with type 2 diabetes. METHODS: In a randomized, double-blind, crossover trial, 19 subjects with type 2 diabetes inhaled filtered air or 50 μg/m(3) elemental carbon UFP (count median diameter, 32 nm) by mouthpiece for 2 hr at rest. We repeatedly measured markers of vascular activation, coagulation, and systemic inflammation before and after exposure. RESULTS: Compared with air, particle exposure increased platelet expression of CD40 ligand (CD40L) and the number of platelet-leukocyte conjugates 3.5 hr after exposure. Soluble CD40L decreased with UFP exposure. Plasma von Willebrand factor increased immediately after exposure. There were no effects of particles on plasma tissue factor, coagulation factors VII or IX, or D-dimer. CONCLUSIONS: Inhalation of elemental carbon UFP for 2-hr transiently activated platelets, and possibly the vascular endothelium, in people with type 2 diabetes.
format Text
id pubmed-3002188
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher National Institute of Environmental Health Sciences
record_format MEDLINE/PubMed
spelling pubmed-30021882010-12-16 Vascular Effects of Ultrafine Particles in Persons with Type 2 Diabetes Stewart, Judith C. Chalupa, David C. Devlin, Robert B. Frasier, Lauren M. Huang, Li-Shan Little, Erika L. Lee, Steven M. Phipps, Richard P. Pietropaoli, Anthony P. Taubman, Mark B. Utell, Mark J. Frampton, Mark W. Environ Health Perspect Research BACKGROUND: Diabetes confers an increased risk for cardiovascular effects of airborne particles. OBJECTIVE: We hypothesized that inhalation of elemental carbon ultrafine particles (UFP) would activate blood platelets and vascular endothelium in people with type 2 diabetes. METHODS: In a randomized, double-blind, crossover trial, 19 subjects with type 2 diabetes inhaled filtered air or 50 μg/m(3) elemental carbon UFP (count median diameter, 32 nm) by mouthpiece for 2 hr at rest. We repeatedly measured markers of vascular activation, coagulation, and systemic inflammation before and after exposure. RESULTS: Compared with air, particle exposure increased platelet expression of CD40 ligand (CD40L) and the number of platelet-leukocyte conjugates 3.5 hr after exposure. Soluble CD40L decreased with UFP exposure. Plasma von Willebrand factor increased immediately after exposure. There were no effects of particles on plasma tissue factor, coagulation factors VII or IX, or D-dimer. CONCLUSIONS: Inhalation of elemental carbon UFP for 2-hr transiently activated platelets, and possibly the vascular endothelium, in people with type 2 diabetes. National Institute of Environmental Health Sciences 2010-12 2010-09-07 /pmc/articles/PMC3002188/ /pubmed/20822968 http://dx.doi.org/10.1289/ehp.1002237 Text en http://creativecommons.org/publicdomain/mark/1.0/ Publication of EHP lies in the public domain and is therefore without copyright. All text from EHP may be reprinted freely. Use of materials published in EHP should be acknowledged (for example, ?Reproduced with permission from Environmental Health Perspectives?); pertinent reference information should be provided for the article from which the material was reproduced. Articles from EHP, especially the News section, may contain photographs or illustrations copyrighted by other commercial organizations or individuals that may not be used without obtaining prior approval from the holder of the copyright.
spellingShingle Research
Stewart, Judith C.
Chalupa, David C.
Devlin, Robert B.
Frasier, Lauren M.
Huang, Li-Shan
Little, Erika L.
Lee, Steven M.
Phipps, Richard P.
Pietropaoli, Anthony P.
Taubman, Mark B.
Utell, Mark J.
Frampton, Mark W.
Vascular Effects of Ultrafine Particles in Persons with Type 2 Diabetes
title Vascular Effects of Ultrafine Particles in Persons with Type 2 Diabetes
title_full Vascular Effects of Ultrafine Particles in Persons with Type 2 Diabetes
title_fullStr Vascular Effects of Ultrafine Particles in Persons with Type 2 Diabetes
title_full_unstemmed Vascular Effects of Ultrafine Particles in Persons with Type 2 Diabetes
title_short Vascular Effects of Ultrafine Particles in Persons with Type 2 Diabetes
title_sort vascular effects of ultrafine particles in persons with type 2 diabetes
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002188/
https://www.ncbi.nlm.nih.gov/pubmed/20822968
http://dx.doi.org/10.1289/ehp.1002237
work_keys_str_mv AT stewartjudithc vasculareffectsofultrafineparticlesinpersonswithtype2diabetes
AT chalupadavidc vasculareffectsofultrafineparticlesinpersonswithtype2diabetes
AT devlinrobertb vasculareffectsofultrafineparticlesinpersonswithtype2diabetes
AT frasierlaurenm vasculareffectsofultrafineparticlesinpersonswithtype2diabetes
AT huanglishan vasculareffectsofultrafineparticlesinpersonswithtype2diabetes
AT littleerikal vasculareffectsofultrafineparticlesinpersonswithtype2diabetes
AT leestevenm vasculareffectsofultrafineparticlesinpersonswithtype2diabetes
AT phippsrichardp vasculareffectsofultrafineparticlesinpersonswithtype2diabetes
AT pietropaolianthonyp vasculareffectsofultrafineparticlesinpersonswithtype2diabetes
AT taubmanmarkb vasculareffectsofultrafineparticlesinpersonswithtype2diabetes
AT utellmarkj vasculareffectsofultrafineparticlesinpersonswithtype2diabetes
AT framptonmarkw vasculareffectsofultrafineparticlesinpersonswithtype2diabetes